Review Article
Variables to Be Monitored via Biomedical Sensors for Complete Type 1 Diabetes Mellitus Management: An Extension of the “On-Board” Concept
Table 1
Current commercialized CGM sensor systems.
| Company | Model | Features | MARD |
| Abbott | | Trend marks Rate-of-change alerts Alarms (hyper/hypo) 5-day lifetime | Calibration recommended up to 72 h | 14.5% [26] | | Trend marks No alerts or alarms 14-day lifetime NFC communication with smartphone | Read approaching meter to sensor (NFC technology) No calibration needed | 11.4% [27] |
| Dexcom | | Trend marks Rate-of-change alerts Alarms (hyper/hypo) 7-day lifetime | Remote monitoring Calibration every 12 h | 13% [28] (Original algorithm) | | Trend marks Rate-of-change alerts Alarms (hyper/hypo) 7-day lifetime | Remote monitoring Wireless communication with smartphone Calibration every 12 h | 9% [29] |
| Medtronic | | Trend marks Rate-of-change alerts Alarms (hyper/hypo) 6-day lifetime | Integration with Medtronic 530G insulin pumps Calibration every 12 h | 13.6% [30] | | Trend arrows Rate-of-change alerts Alarms (hyper/hypo) 7-day lifetime | Integration with Medtronic 670G insulin pumps Calibration every 12 h | 9.1% [31] |
| Senseonics | | Trend arrows Rate-of-change alerts Alarms (hyper/hypo) 90-day lifetime | Communication with smartphone Sensor inserted under the skin | 11.6% [32] |
|
|